Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson's disease

Z Fan, YT Pan, ZY Zhang, H Yang, SY Yu… - Journal of …, 2020 - Springer
Background Emerging evidence indicates that inflammasome-induced inflammation plays a
crucial role in the pathogenesis of Parkinson's disease (PD). Several proteins including α …

Inflammasome and α-synuclein in Parkinson's disease: a cross-sectional study

K Chatterjee, A Roy, R Banerjee, S Choudhury… - Journal of …, 2020 - Elsevier
Background Alpha-synuclein and inflammatory pathology are evident in Parkinson's disease
(PD) but, their link to disease pathogenesis needs further elucidation. Objectives To explore …

Role of NLRP3 inflammasome in Parkinson's disease and therapeutic considerations

LTN Nguyen, HD Nguyen, YJ Kim… - Journal of …, 2022 - content.iospress.com
Parkinson's disease (PD) is the second most common neurodegenerative disease, with two
main pathological features: misfolded α-synuclein protein accumulation and …

Plasma-borne indicators of inflammasome activity in Parkinson's disease patients

FL Anderson, KM von Herrmann, AS Andrew… - NPJ Parkinson's …, 2021 - nature.com
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-
motor symptoms and loss of dopaminergic neurons of the substantia nigra. Inflammation and …

Targeting microglial α-synuclein/TLRs/NF-kappaB/NLRP3 inflammasome axis in Parkinson's disease

Y Li, Y Xia, S Yin, F Wan, J Hu, L Kou, Y Sun… - Frontiers in …, 2021 - frontiersin.org
According to emerging studies, the excessive activation of microglia and the subsequent
release of pro-inflammatory cytokines play important roles in the pathogenesis and …

NLRP3 inflammasome-mediated neuroinflammation and related mitochondrial impairment in Parkinson's disease

QQ Han, W Le - Neuroscience Bulletin, 2023 - Springer
Parkinson's disease (PD) is a common neurodegenerative disorder caused by the loss of
dopamine neurons in the substantia nigra and the formation of Lewy bodies, which are …

α-synuclein promotes progression of Parkinson's disease by upregulating autophagy signaling pathway to activate NLRP3 inflammasome

X Wang, J Chi, D Huang, L Ding… - Experimental and …, 2020 - spandidos-publications.com
Mechanism by which α-synuclein affects the progression of Parkinson's disease through
Pyrin Domain Containing Protein 3 (NLRP3) was explored. Peripheral blood plasma of 40 …

The NLRP3 inflammasome is involved in the pathogenesis of Parkinson's disease in rats

Z Mao, C Liu, S Ji, Q Yang, H Ye, H Han, Z Xue - Neurochemical research, 2017 - Springer
The etiology and pathogenesis of Parkinson's disease (PD) are complicated and have not
been fully elucidated, but an important association has been identified between …

p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease

J Chen, K Mao, H Yu, Y Wen, H She, H Zhang… - Journal of …, 2021 - Springer
Background Parkinson's disease (PD) is characterized by degeneration of dopaminergic
neurons in the substantia nigra pars compacta (SNpc), accompanied by accumulation of α …

MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease

Y Zhou, M Lu, RH Du, C Qiao, CY Jiang… - Molecular …, 2016 - Springer
Abstract Background α-Synuclein (α-Syn), a pathological hallmark of Parkinson's disease
(PD), has been recognized to induce the production of interleukin-1β in a process that …